Tocqueville Asset Management L.P. Inovio Pharmaceuticals, Inc. Transaction History

Tocqueville Asset Management L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$9.57 - $27.05 $76,560 - $216,400	-8,000 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$7.14 - $31.69 $132,090 - $586,265	-18,500 Reduced 69.81%	8,000 $216,000
Q1 2020 May 15, 2020	SELL	$2.98 - $14.09 $59,004 - $278,982	-19,800 Reduced 42.76%	26,500 $197,000
Q4 2019 Jan 14, 2020	SELL	$1.97 - $3.72 $19,700 - $37,200	-10,000 Reduced 17.76%	46,300 $153,000
Q3 2019 Oct 31, 2019	SELL	$2.05 - $3.02 $32,800 - $48,320	-16,000 Reduced 22.13%	56,300 $115,000
Q2 2019 Jul 31, 2019	BUY	$2.29 - $4.1 $27,480 - $49,199	12,000 Added 19.9%	72,300 $213,000
Q1 2019 Apr 30, 2019	BUY	$3.34 - $5.1 $201,402 - $307,530	60,300 New	60,300 $225,000
Q3 2018 Nov 13, 2018	SELL	$3.92 - $5.58 $115,640 - $164,610	-29,500 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$4.05 - $5.69 $94,770 - $133,146	-23,400 Reduced 44.23%	29,500 $139,000
Q4 2017 Feb 13, 2018	BUY	$4.13 - $6.68 $218,477 - $353,372	52,900	52,900 $218,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $1.06B
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.